Edition:
United States

ProQR Therapeutics NV (PRQR.OQ)

PRQR.OQ on NASDAQ Stock Exchange Global Market

2.80USD
3:59pm EST
Change (% chg)

$-0.05 (-1.75%)
Prev Close
$2.85
Open
$2.85
Day's High
$2.85
Day's Low
$2.78
Volume
10,599
Avg. Vol
29,193
52-wk High
$6.85
52-wk Low
$2.78

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.33 -0.416
Jun '17 0.26 -0.474
Mar '17 0.39 -0.446
FY 2016 Dec '16 0.10 -0.378
Sep '16 0.45 -0.434
Jun '16 0.59 -0.427
Mar '16 0.69 -0.437
FY 2015 Dec '15 0.96 -0.262
Sep '15 1.19 -0.271
Jun '15 0.75 -0.369
Mar '15 0.34 0.010
 
*Note: Units in Millions ofEuro
**Note: Units in Euro

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 2 0.16 0.32 0.00 1.00
Year Ending Dec-17 2 1.26 1.41 1.10 1.02
Year Ending Dec-18 2 0.56 1.11 0.00 1.70
Earnings (per share)
Quarter Ending Dec-17 2 -0.45 -0.40 -0.49 -0.53
Year Ending Dec-17 2 -1.98 -1.91 -2.05 -1.64
Year Ending Dec-18 2 -1.54 -1.31 -1.78 -1.66
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 185.97 35.27
P/E High - Last 5 Yrs. -- 274.53 45.26
P/E Low - Last 5 Yrs. -- 92.51 24.18
Beta -- 0.83 0.91
Price to Sales (TTM) 72.25 114.29 5.83
Price to Book (MRQ) 1.92 22.17 5.62
Price to Tangible Book (MRQ) 2.40 25.97 7.22
Price to Cash Flow (TTM) -- 101.40 24.19
% Owned Institutions 46.24 5.64 1.41

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.50
Dividend Yield - 5 Year Avg -- 0.26 2.04
Dividend 5 Year Growth Rate -- 1.96 5.26
Payout Ratio(TTM) -- 96.00 46.03

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -27.07 -3.18 6.84
Sales (TTM) vs TTM 1 Yr. Ago -59.49 30.07 5.66
Sales - 5 Yr. Growth Rate -- 33.24 10.25
EPS (MRQ) vs Qtr. 1 Yr. Ago 4.15 -149.23 7.22
EPS (TTM) vs TTM 1 Yr. Ago -9.88 -- --
EPS - 5 Yr. Growth Rate -- 43.30 10.92
Capital Spending - 5 Yr. Growth Rate -- 40.86 15.14

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.79 2.54
Current Ratio (MRQ) 6.72 5.74 3.56
LT Debt to Equity (MRQ) 19.80 14.43 13.40
Total Debt to Equity (MRQ) 19.80 16.88 19.46
Interest Coverage (TTM) -- -147.14 44.80

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 43.80 54.92
Gross Margin - 5 Yr. Avg. -- 55.48 52.46
EBITD Margin (TTM) -3,583.81 -- --
EBITD - 5 Yr. Avg -- -218.62 15.49
Operating Margin (TTM) -3,682.61 -632.11 6.65
Operating Margin - 5 Yr. Avg. -- -235.48 10.97
Pre-Tax Margin (TTM) -3,788.50 -603.10 7.47
Pre-Tax Margin - 5 Yr. Avg. -- -235.80 11.38
Net Profit Margin (TTM) -3,788.69 -600.62 3.70
Net Profit Margin - 5 Yr. Avg. -- -239.05 7.67
Effective Tax Rate (TTM) -- 15.26 24.26
Effective Tax Rate - 5 Yr. Avg. -- 18.70 24.06

Efficiency

  Company industry sector
Revenue/Employee (TTM) 9,618 21,614,065 848,695,288
Net Income/Employee (TTM) -364,393 -1,754,114 99,009,570
Receivable Turnover (TTM) -- 25.64 6.11
Inventory Turnover (TTM) -- 2.61 3.55
Asset Turnover (TTM) 0.02 0.42 0.96

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -69.56 -9.38 11.28
Return on Assets - 5 Yr. Avg. -- 0.11 12.25
Return on Investment (TTM) -78.98 -11.84 14.40
Return on Investment - 5 Yr. Avg. -- 3.18 16.04
Return on Equity (TTM) -87.43 -36.93 15.99
Return on Equity - 5 Yr. Avg. -- 5.57 17.25
  1 Year 3 Year 5 Year
Sales % -43.49 150.71 --
EPS (TTM) % -87.68 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for ProQR Therapeutics NV

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 46.27%
# of Holders: 39
Total Shares Held: 14,741,190
3 Mo. Net Change: 2,583,081
# New Positions: 10
# Closed Positions: 1
# Increased Positions: 20
# Reduced Positions: 7
# Net Buyers: 13
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.